SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

High Roller Technologies, Inc. is an evolving and growth-oriented iCasino and entertainment company, which engages in the business of operating an online gaming business offering casino betting games to customers. The firm also offers a wide range of games including many that are available in land-based casinos, such as blackjack, roulette, baccarat, poker, and slot machines. The company was founded by Michael Alexander Cribari and Brandon Christopher Eachus on December 21, 2021 and is headquartered in Las Vegas, NV.

High Roller Technologies Inc.

High Roller Technologies Inc

High Roller Technologies is trending due to a strategic partnership with Crypto.com to launch an exclusive U.S. prediction markets platform, coupled with plans for sports betting expansion. The community is actively discussing the stock's significant surge, high volume, and potential for a short squeeze given its low float. However, some are also debating the possibility of future share offerings amidst the intense market activity.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as digital video compact disc player, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

Taiwan Semiconductor is trending sharply following a stellar earnings report that surpassed expectations with strong margins and aggressive capital expenditure plans, driven by persistent AI chip demand. The community is actively discussing the CEO's "AI megatrend" outlook, interpreting the results as a significant bullish indicator for the entire semiconductor sector. This strong performance is expected to generate positive momentum for related companies in the AI supply chain.

BRC Group Holdings, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

BRC Group Holdings Inc.

B. Riley Financial Inc

B. Riley Financial (RILY) is experiencing an intense surge of conversation following its Q3 financial report release, which arrived significantly ahead of its NASDAQ compliance deadline and indicated a strong return to profitability. The news has ignited fervent discussions among traders, who are anticipating a major short and gamma squeeze due to high short interest and renewed confidence as delisting fears subside. The community is actively debating the potential for a substantial upward movement, with many drawing parallels to historical market squeezes like CVNA or GME.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is currently a focal point for investors, navigating ongoing Wall Street downgrades alongside intense discussion around a potential credit card interest rate cap and its implications for the company's Buy Now Pay Later services. Despite significant community frustration regarding recent stock performance and calls for leadership changes, many perceive PYPL as fundamentally undervalued, citing robust financials and strategic AI partnerships. This creates a deeply divided sentiment, with some confidently calling a bottom while others anticipate further price erosion amid concerns of market manipulation.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is experiencing heightened investor interest and significant trading volume, fueled by speculation of a gamma squeeze driven by expiring call options and community enthusiasm for its Optical Interposer technology. This core innovation for high-speed, energy-efficient AI data center interconnects is generating strong anticipation for upcoming news on strategic partnerships and product developments, despite reports of some online brokers restricting buy orders.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares

SOXL is trending sharply higher, propelled by robust sentiment across the semiconductor industry amid encouraging economic data and positive earnings reports from key players like TSMC. The community is actively debating its substantial rally, with many anticipating continued upside driven by insatiable AI demand, while others signal caution about an "AI bubble" and potential for profit-taking given its leveraged nature. Upcoming tech conferences, such as CES, further highlight the sector's pivotal role in technological advancements.

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Advanced Micro Devices is trending due to a strategic collaboration with Tata Consultancy Services aimed at accelerating enterprise AI adoption, alongside a significant analyst upgrade. The community is actively discussing strong hyperscaler demand that reportedly has AMD's server CPUs largely sold out through 2026, with high anticipation for its MI300 series AI accelerators. This underscores AMD's growing leadership and momentum in the high-performance computing and artificial intelligence sector.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending amidst reports that Sanofi is preparing an improved takeover bid after its initial offer was rejected, sparking community discussions about a potential bidding war. This acquisition interest coincides with high anticipation for the upcoming SOL-1 Phase 3 trial data for AXPAXLI, expected in Q1 2026, which many believe could significantly re-rate the company. Investors are closely watching, noting institutional accumulation and the potential for the long-acting wet AMD therapy to reshape the market.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

United States Antimony Corp (UAMY) is trending as discussions intensify around antimony's critical status for national security and defense, with the market anticipating further government support and updates on expanded domestic production. The community is actively bullish on UAMY's unique position as a current supplier to the U.S. military, particularly given increasing geopolitical tensions and global efforts to reduce reliance on foreign critical mineral sources.

The GEO Group, Inc. engages in the design, financing, development, and support services for secure facilities, processing centers, and community re-entry facilities. It operates through the following segments: U.S. Secure, Electronic Monitoring and Supervision, Reentry, and International Services. The U.S. Secure Services segment encompasses the United States-based public-private partnership corrections and detention business. The Electronic Monitoring and Supervision Services segment conducts its services in the U.S. The Reentry Services Segment consists of various community-based and reentry services. The International Services segment consists of public-private partnership secure services operations in Australia and South Africa. The company was founded by George C. Zoley in 1984 and is headquartered in Boca Raton, FL.

Geo Group, Inc.

GEO Group is trending as it secures new contracts, including a significant agreement with ICE for immigration monitoring (ISAP) and additional correctional facility management in Florida, sparking bullish speculation. The community is actively discussing the company's valuation, anticipating substantial revenue growth and stock buybacks, driven by a perceived increase in demand for its services amid ongoing political debates and enforcement actions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Receives Consensus Rating of "Moderate Buy" from Brokerages

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC - Get Free Report) has earned an average recommendation of "Moderate Buy" from the seven brokerages that are covering the company, MarketBeat.com reports...

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Given Consensus Recommendation of "Moderate Buy" by Brokerages

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC - Get Free Report) has been assigned an average rating of "Moderate Buy" from the seven ratings firms that are currently covering the firm, Marketbeat...

DiaMedica Therapeutics (NASDAQ:DMAC) Trading Up 7.4% - Here's Why

DiaMedica Therapeutics (NASDAQ:DMAC) Shares Up 7.4% - Here's Why...

DiaMedica Therapeutics (NASDAQ:DMAC) Sets New 1-Year High - Time to Buy?

DiaMedica Therapeutics (NASDAQ:DMAC) Hits New 1-Year High - Here's What Happened...

Jan Stahlberg Buys 128,426 Shares of DiaMedica Therapeutics (NASDAQ:DMAC) Stock

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC - Get Free Report) major shareholder Jan Stahlberg acquired 128,426 shares of the business's stock in a transaction that occurred on Thursday, November 20th...

Insider Buying: DiaMedica Therapeutics (NASDAQ:DMAC) Major Shareholder Purchases 128,426 Shares of Stock

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC - Get Free Report) major shareholder Jan Stahlberg acquired 128,426 shares of DiaMedica Therapeutics stock in a transaction dated Thursday, November 20th...

DiaMedica Therapeutics (NASDAQ:DMAC) Major Shareholder Acquires $1,234,453.50 in Stock

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC - Get Free Report) major shareholder Jan Stahlberg bought 182,882 shares of the company's stock in a transaction that occurred on Tuesday, November 18th. The...

DiaMedica Therapeutics (NASDAQ:DMAC) Major Shareholder Acquires $1,221,802.36 in Stock

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC - Get Free Report) major shareholder Jan Stahlberg bought 187,393 shares of the firm's stock in a transaction that occurred on Monday, November 17th. The...

Jan Stahlberg Acquires 208,872 Shares of DiaMedica Therapeutics (NASDAQ:DMAC) Stock

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC - Get Free Report) major shareholder Jan Stahlberg bought 208,872 shares of the business's stock in a transaction dated Friday, November 21st. The stock was...

Jan Stahlberg Acquires 240,352 Shares of DiaMedica Therapeutics (NASDAQ:DMAC) Stock

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC - Get Free Report) major shareholder Jan Stahlberg bought 240,352 shares of the firm's stock in a transaction on Wednesday, November 19th. The stock was...

DiaMedica Therapeutics, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It develops the DM199 product candidate, which focuses on acute ischemic stroke (AIS) and chronic kidney disease (CKD). The company was founded by Wayne Lautt on January 21, 2000 and is headquartered in Minneapolis, MN.

DiaMedica Therapeutics Inc

Short-Term Volatility, Then Markets Move On

Sustained Risk-Off Until Fed Path Is Clear

Little Impact — Fundamentals Still Rule

Other – Comment Below

Markets pulled back after reports that the DOJ opened a criminal investigation into Federal Reserve Chair Jerome Powell, raising concerns about central bank independence. With rate cuts, inflation, and political pressure all in focus, how do you think this standoff will impact markets in 2026?

How Will the Powell Investigation Impact Markets in 2026?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.18	--	--	N/A
Q3 '25	-$0.16	-$0.17	-6.25%	MISSED
Q2 '25	-$0.19	-$0.18	5.26%	BEAT
Q1 '25	-$0.18	-$0.18	--	EXPECTED
Q4 '24	-$0.17	-$0.18	-4.35%	MISSED

DMAC
DiaMedica Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest DMAC News

DMACDiaMedica Therapeutics Inc